Compile Data Set for Download or QSAR
Report error Found 87 Enz. Inhib. hit(s) with all data for entry = 11831
TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651900(US20240051956, Example 68)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651908(US20240051956, Example 72)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651907(US20240051956, Example 33)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651906(US20240051956, Example 71)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651905(US20240051956, Example 32)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651904(US20240051956, Example 70)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651903(US20240051956, Example 31)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651902(US20240051956, Example 69)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651901(US20240051956, Example 30)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651909(US20240051956, Example 34)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651899(US20240051956, Example 29)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651896(US20240051956, Example 66)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651886(US20240051956, Example 61)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651883(US20240051956, Example 21)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651882(US20240051956, Example 59)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651881(US20240051956, Example 20)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651880(US20240051956, Example 58)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651879(US20240051956, Example 19)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651919(US20240051956, Example 39)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651927(US20240051956, Example 85)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651926(US20240051956, Example 84)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651925(US20240051956, Example 83)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651924(US20240051956, Example 82)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651923(US20240051956, Example 81)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651922(US20240051956, Example 80)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651921(US20240051956, Example 79)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651920(US20240051956, Example 78)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651844(US20240051956, Example 40)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651918(US20240051956, Example 77)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651917(US20240051956, Example 38)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651915(US20240051956, Example 37)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651914(US20240051956, Example 75)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651913(US20240051956, Example 36)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651912(US20240051956, Example 74)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651911(US20240051956, Example 35)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651910(US20240051956, Example 73)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651856(US20240051956, Example 46)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651867(US20240051956, Example 13)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651866(US20240051956, Example 51)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651865(US20240051956, Example 12)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651864(US20240051956, Example 50)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651863(US20240051956, Example 11)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651862(US20240051956, Example 49)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651861(US20240051956, Example 10)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651860(US20240051956, Example 48)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651859(US20240051956, Example 9)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651858(US20240051956, Example 47)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651857(US20240051956, Example 8)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651877(US20240051956, Example 18)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

TargetGTPase KRas [1-169,G12D]/Son of sevenless homolog 1 [564-1049](Human)
Qilu Regor Therapeutics

US Patent
LigandPNGBDBM651855(US20240051956, Example 7)
Affinity DataIC50: 15nMAssay Description:This assay is used to examine the potency with which compounds inhibit the protein protein interaction between SOS1 and KRAS G12D in a defined bioche...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2024
Entry Details
Go to US Patent

Displayed 1 to 50 (of 87 total ) | Next | Last >>
Jump to: